Wellness Industries
Health
Eurecat provides knowledge and innovative technologies to work together with businesses in the health sector value chain
In Health we work to develop new standout products, processes, services and solutions supporting businesses, hospitals and health institutions from the idea to its industrialisation.
Solutions to transform healthcare
1
Smart hospital of the future (Hospital 4.0)
- Planning, optimising and reengineering healthcare processes
- Control centre with digital twins, simulation tools and dashboard for smart hospital management
- Liquid hospitals, home hospitalisation and hyper-specialisation of intra-hospitalservices
- Healthcare robotics and artificial intelligence for automation and smart support
- Health products, medical devices and PoC to enable and standardise diagnosis, intervention and monitoring
2
Integrated care and chronicity management
- Self-management tools for patients and caregivers
- Collaboration tools for healthcare and social professionals
- Advanced services: patient empowerment, training, communication, follow-up, workflow management
- Planning and monitoring the adaptive and flexible care plan
- Virtual healthcare practice to reduce unnecessary trips and visits to optimise and prioritise added-value face-to-face visits
- Improved adherence to treatments, not just pharmacological ones
3
Support systems for precision medicine
- Data analytics in medicine: analysis and fusion of clinical, epidemiological picture, biological and environmental data
- Application of statistical techniques, especially artificial intelligence and machine learning
- Predictive and prescriptive models
- Clinical decision support systems for screening, diagnosis, prognosis, therapy management and personalisation
4
Personalised medicine
- Holistic and multilevel approach to the omic sciences: genomics, transcriptomics, proteomics, metabolomics
- Understanding and interpreting the mechanisms of complex diseases from a deep biological perspective
- Personalisation of medicine for each individual based on biology and interaction with the phenotype
- Personalisation of pharmacological and non-pharmacological treatments, therapies and rehabilitation
- Personalisation of biologically-based nutrition and interaction with lifestyle
5
Personalised medical devices
- Design, development and functional validation of medical devices
- Advanced and customised materials for implants, prostheses and orthotic devices
- Automated generation of customised models of implants, prostheses and orthotic devices
- Flexible and plastronic functional printing to implement medical devices with flexible electronics, sensors and nanomaterials
- Smart and functional fabrics for health monitoring (wearables)
- AI embedded in sensors and actuators for predictive medicine and PoC
6
Robotics to support physical and cognitive rehabilitation
- Collaborativeand adaptive robotics
- Robot behaviour engines
- Recognising emotions and mood based on physiological signals
- EEG, ECG, EDA, gesture and expression analysis
- Digital therapeutics delivered through multimodal platforms including sensorised robots
- Virtual and augmented reality for medical treatments and surround sound to apply audio-based therapies
7
Biosensors, lab-on-a-chip, organ-on-a-chip
- Choice and validation of biomarkers in the design of biosensors and lab-on-a-chip , setup in the lab and translation on the device
- Using omicsdata for organ-on-a-chip or lab-on-a-chip device characterisation , validation of suitability to test the biological effectiveness of active principles, ingredients or drugs
- Microfluidics and flexible electronics technology to recreate organ activity and test new bioactive compounds
- 3D bioprinting and biocompatibility
8
Personalised nutrition
- Personalisation of biologically-based nutrition and interaction with lifestyle
- AI approach to provide nutritional recommendations targeting people, functional microbiota. Traditional and emerging technologies to design, characterise and transform new ingredients meeting consumer preferences
- Assessment of biological efficacy and description of the molecular mechanisms involved in the biological actions of foods, extracts, nutraceuticals, bioactive ingredients
OCA-WAS, the Eurecat control entity accredited according to the UNE-EN ISO/IEC 17020 standard in the field of major accidents
Eurecat offers companies the OCA-WAS control body with the aim of supporting the professional activity of companies through the evaluation of safety reports (SI) and Quantitative Risk Analysis reports (QRA).
We have the necessary technical means to prevent accidents involving hazardous substances, thus limiting their consequences on human health and the environment.
Services
Biotech companies
- Omics data generation (genomics, proteomics and metabolomics) and bioinformatics analysis of the data and machine learning in case of large data volumes
- Stability, useful life and bioavailability studies for biotechnological molecules
- Lab-on-a-chip and organ-on-a-chip technology development
- In vitro, preclinical (in vivo) and clinical studies
- Identification and characterisation of prebiotics, probiotics, postbiotics and paraprobiotics
- Fermentation optimisation and scaling services
Medical technology companies
- Medical devices development
- Innovation in existing health products
- Wearables to capture, measure and control biometric signals and parameters
- Biomechanical analysis and rehabilitationdevices
- AI-embedded smart patches
- Flexible, plastronic, sensory electronics and touchless devices
- Application of functional surface treatments (functional nanotexturing)
- Application of microencapsulation for treatments in health products
- Services and development for disinfection
- Developing apps and platforms for patient-professional interaction
- Data mining platforms
Pharmaceutical companies
- Generation of omic data, bioinformatics analytics and processing large volumes of data
- Microbiota studies (intestinal, dermal, environmental, etc.)
- NMR-based interactomics studies
- Epigenomics (DNA methylation, ChIP-Seq)
- Guided proteomics for vaccine antigen characterisation
- Intact protein proteomics and their post-translational modifications for characterising products of pharmacological interest
- Studies of stability, useful life, bioavailability and pharmacokinetics of molecules
- In vitro, preclinical (in vivo) and clinical studies
- Identification and characterisation of prebiotics, probiotics, postbiotics and paraprobiotics
- Preclinical studies targeting screening/high-throughput models, an alternative to small mammal ones (organ-on-a-chip for digestive health and zebrafish larvae)
- Digestive health using advanced in vitro models (OOC) with microbiota modulating ingredients
- Smart traceability projects (smart blisters)
- Data analytics, machine learning and big data environment projects and studies for analysis and knowledge of consumers and the professional doctor channel or the distribution channel
- Sustainability projects (energy efficiency, waste management, CO2 footprint, etc.)
- Development of separation and purification processes
- Treatment of recalcitrant compounds in wastewater
- Biomanufacturing: bioprinters, 3D stents, organ-on-a-chip, scaffolds, melt electrospinning
Research centres
- Omics procedures and analytics with bioinformatics analysis of the data obtained
- Microbiota studies (intestinal, dermal, environmental, etc.)
- NMR-based interactomics studies
- Epigenomics (DNA methylation, ChIP-Seq)
- Guided proteomics for vaccine antigen characterisation
- Data analytics, machine learning and big data environment projects and studies
- Preclinical and clinical studies
- Preclinical studies targeting screening/high-throughput models, an alternative to small mammal ones (organ-on-a chip for digestive health and zebrafish larvae)
- Smart traceability projects (smart blisters)
- Biomanufacturing: bioprinters, 3D stents, organ-on-a-chip, scaffolds, melt electrospinning)
Care providers
- Omics data procedures and studies with bioinformatics analysis of the data and machine learning in case of large data volumes
- Precision nutrition studies (personalised or group)
- Applications and platforms for patients and professionals
- Health promotion studies using digital tools
- Point-of-care development for rapid diagnosis
- Biomechanical analysis and rehabilitation devices
- Wearables to measure and control biometric signals and parameters
- Indoor positioning of the asset and people
- Consulting, managing and unlocking innovation
- Health services through care and social robotics platforms
- Hospital 4.0
Private clinics
- Molecular studies for private clinics (genotyping, gene expression studies, microbiota analysis, metabolome analysis, metabotyping studies, etc.) with various biological fluids and tissues (urine, faeces, saliva, sweat, tears, cerebrospinal fluid, etc.)
- Annual testing agreements with studies of large numbers of samples or more recurrent or regular samples
- Skin health studies
- Metabolic analyses in both faeces and plasma (fatty acids, bile acids, lipidomics, amino acids, acylcarnitines, etc.)
- Functional microbiota studies including metagenomics and metaproteomics studies
- Studies of post-translational modifications (PTMs)
- Development of digital platforms for professionals
- Health promotion and follow-up studies using digital tools
Ministry of Health (government)
- Public health analysis tools
- Analysis of the impact of epidemics
- Analysis of the impact of the environment
- Analysis of the impact of climate change on health
Contact
Francesc Massana
Head of Health and Sports Markets
- Tel. +34 689 62 61 75
- francesc.massana[at]eurecat.org
Xavi Catasús
Head of Business Development Wellness Industries
Degree in Geological Sciences at the University of Barcelona. He has developed practically his entire professional career since 1994 in the Health sector linked to ICT. Initially in consultancy and pre-sales tasks and, later, evolving towards more commercial (less technical) tasks as head of a business unit and commercial management. He has experience in the entire sales cycle of products, software solutions and services, medical devices, etc. He currently works as a Business Development Manager in the Wellness sector.
- Tel. +34 637 816 439
- xavi.catasus[at]eurecat.org
Cross-cutting services
Innovation technology consulting and sector training
- Technology watch, sector trends “radar” and competitive intelligence
- Innovation strategy: Lean management, Industry 4.0 Roadmaps, Circular Economy Roadmap
- Intellectual/industrial property studies
- Technological due diligence
- Specialised training: Industry 4.0, cybersecurity, artificial intelligence, circular economy, robotics
- Entrepreneurship training programmes
Product development
- Conceptualisation and proofs-of-concept
- Prototyping
- Short runs and field validation
- Support for industrialising
- Certification support
Industry 4.0 and Artificial Intelligence
- Smart platforms for controlling sensors and data
- Data architecture: information system cross-correlation and analytics for decision making
- Determination of complex parameters using virtual sensors (soft sensing)
- Integration and communication of information with management systems
Cybersecurity
- Secure information exchange using digital smart contracts and blockchain
- Solutions for the digital security of equipment and facilities
- Solutions for the digital security of medical devices
- Control system for cyber-physical threats in critical infrastructures
Facilities
Outstanding projects
Dipneo
Dipneo is to develop and market a new medical device for resuscitation in case of cardiorespiratory arrest. It is based on a new system patented by Eurecat which allows air to be blown into the patient autonomously.
Evisió
Ophthalmology Territorial Innovation Project for decentralising care, online vision self-testing and user empowerment. The main goal is to improve the eye health of people in l’Alt Empordà by making it easier for patients to get ophthalmological care and reducing referrals.
NHOA
Never Home Alone. Social assistance robotic system to prevent loneliness and isolation by helping the elderly to live independently at home.
Sarsaigua
Setting up the wastewater analytical surveillance platform. The goal is to monitor genetic traces of the SARS-COV-2 virus in Catalan wastewater treatment plants to control its concentration in towns and thus implement preventive measures to curb its spread.
Success stories
Fundació Salut Empordà
Fundació Salut Empordà and Eurecat develop screening and diagnostic tools that allow for greater efficiency and an immediate response in the field of improving ophthalmological care.
Sector news
International study backs Mediterranean diet in families to foster healthy and sustainable habits
The Eurecat technology centre has taken part in an international study involving 250 families with school-age children in Spain [...]
IAS and Eurecat technology centre seal partnership agreement to drive healthcare innovation
Institut d’Assistència Sanitària and the Eurecat technology centre have inked a partnership agreement to promote joint scientific research and [...]
Smart device to prevent falls in elderly people with cognitive impairment
The Eurecat technology centre has developed a smart device in conjunction with the Sant Víctor nursing home to prevent [...]
Eurecat develops social robot that connects with people to ease communication in clinical settings
Starting today at the Mobile World Congress, the Eurecat technology centre is showcasing the Jana social care robot which [...]
Eurecat and Hospital Sant Joan de Déu design social robot to help children and teenagers with palliative needs at home
The Eurecat technology centre and Hospital Sant Joan de Déu have designed a desktop social robot to help paediatric [...]
Centre for Omic Sciences to address the role of microbiota in nutritional, clinical and environmental studies
This October, the second Symposium of the Centre for Omic Sciences, a joint unit of the Eurecat technology centre [...]
